Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05325242 · ClinicalTrials.gov registry record · NA
Elbow Artery Embolization for Tennis Elbow
A NA study of Lateral Epicondylitis, Unspecified Elbow, sponsored by Siddharth Padia, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT05325242 is a NA study of Lateral Epicondylitis, Unspecified Elbow that is actively recruiting participants, run by Siddharth Padia, MD. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05325242, a NA study of Lateral Epicondylitis, Unspecified Elbow, is actively recruiting participants, sponsored by Siddharth Padia, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical research study is to examine whether embolization treatment of an elbow artery is a safe and effective way to treat elbow pain, specifically pain from tennis elbow. Embozene is a medical device made by Varian marketed in the United States for the treatment of hypervascular tumors and arteriovenous malformations. It consists of thousands of microscopic spheres that are injected into the artery to block the flow of blood to a specific region. One of the causes of pain in the setting of tennis elbow is increased blood flow going to the specific area of pain. In this study, we will investigate an experimental procedure to decrease the blood flow (embolize) to the specific region of the elbow that is causing the pain. This will be done by infusing Embozene particles into the specific blood vessel supplying the area of pain in the elbow. This is an investigational study to evaluate the safety and efficacy of elbow artery embolization (EAE) for the treatment of symptomatic lateral epicondylitis (tennis elbow).
Conditions Studied
Interventions
- DEVICE Embozene particles
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-03-21 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05325242
The ClinicalTrials.gov registry entry for NCT05325242 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Siddharth Padia, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lateral Epicondylitis, Unspecified Elbow appearing as the primary indexed condition, and to 1 intervention - of which Embozene particles is the first listed.
NCT05325242 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05325242 about?
NCT05325242 is a clinical study titled "Elbow Artery Embolization for Tennis Elbow". The purpose of this clinical research study is to examine whether embolization treatment of an elbow artery is a safe and effective way to treat elbow pain, specifically pain from tennis elbow. Embozene is a medical device made by Varian marketed in the United States for the treatment of hypervascul...
What is the current status of trial NCT05325242?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2023-03-21. Estimated completion is 2027-12-31.
What conditions does trial NCT05325242 study?
This clinical trial studies the following conditions: Lateral Epicondylitis, Unspecified Elbow.
What interventions are being tested in trial NCT05325242?
The interventions under investigation include: Embozene particles (DEVICE).
Who is sponsoring clinical trial NCT05325242?
This trial is sponsored by Siddharth Padia, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05325242 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lateral Epicondylitis, Unspecified Elbow
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.